VERA
Price
$21.81
Change
-$0.07 (-0.32%)
Updated
Jul 25 closing price
Capitalization
1.39B
11 days until earnings call
XBIO
Price
$3.60
Change
-$0.04 (-1.10%)
Updated
Jul 25 closing price
Capitalization
5.56M
Interact to see
Advertisement

VERA vs XBIO

Header iconVERA vs XBIO Comparison
Open Charts VERA vs XBIOBanner chart's image
Vera Therapeutics
Price$21.81
Change-$0.07 (-0.32%)
Volume$946.35K
Capitalization1.39B
Xenetic Biosciences
Price$3.60
Change-$0.04 (-1.10%)
Volume$88.58K
Capitalization5.56M
VERA vs XBIO Comparison Chart in %
Loading...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VERA vs. XBIO commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VERA is a Buy and XBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (VERA: $21.81 vs. XBIO: $3.60)
Brand notoriety: VERA and XBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VERA: 51% vs. XBIO: 95%
Market capitalization -- VERA: $1.39B vs. XBIO: $5.56M
VERA [@Biotechnology] is valued at $1.39B. XBIO’s [@Biotechnology] market capitalization is $5.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VERA’s FA Score shows that 1 FA rating(s) are green whileXBIO’s FA Score has 1 green FA rating(s).

  • VERA’s FA Score: 1 green, 4 red.
  • XBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIO is a better buy in the long-term than VERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VERA’s TA Score shows that 5 TA indicator(s) are bullish while XBIO’s TA Score has 3 bullish TA indicator(s).

  • VERA’s TA Score: 5 bullish, 4 bearish.
  • XBIO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, VERA is a better buy in the short-term than XBIO.

Price Growth

VERA (@Biotechnology) experienced а -5.38% price change this week, while XBIO (@Biotechnology) price change was -1.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.39B) has a higher market cap than XBIO($5.56M). XBIO YTD gains are higher at: -9.687 vs. VERA (-48.428). XBIO has higher annual earnings (EBITDA): -3.88M vs. VERA (-167.77M). VERA has more cash in the bank: 590M vs. XBIO (5.16M). XBIO has less debt than VERA: XBIO (153K) vs VERA (54.5M). XBIO has higher revenues than VERA: XBIO (2.58M) vs VERA (0).
VERAXBIOVERA / XBIO
Capitalization1.39B5.56M25,031%
EBITDA-167.77M-3.88M4,326%
Gain YTD-48.428-9.687500%
P/E RatioN/AN/A-
Revenue02.58M-
Total Cash590M5.16M11,425%
Total Debt54.5M153K35,621%
FUNDAMENTALS RATINGS
XBIO: Fundamental Ratings
XBIO
OUTLOOK RATING
1..100
97
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VERAXBIO
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBMLX19.200.23
+1.21%
Neuberger Berman Mid Cap Growth Inst
RYCYX147.271.26
+0.86%
Rydex Dow 2x Strategy C
BFTUX66.090.45
+0.69%
Baron Fifth Avenue Growth R6
LMESX37.850.08
+0.21%
ClearBridge Appreciation IS
TNBAX20.300.02
+0.12%
1290 SmartBeta Equity A

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
-0.32%
KYMR - VERA
59%
Loosely correlated
-0.13%
LYRA - VERA
54%
Loosely correlated
-2.33%
OPORF - VERA
50%
Loosely correlated
N/A
BPMC - VERA
46%
Loosely correlated
N/A
BNTX - VERA
40%
Loosely correlated
+0.65%
More

XBIO and

Correlation & Price change

A.I.dvisor tells us that XBIO and NKTR have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XBIO and NKTR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIO
1D Price
Change %
XBIO100%
-1.00%
NKTR - XBIO
27%
Poorly correlated
+1.71%
ELEV - XBIO
27%
Poorly correlated
N/A
VERA - XBIO
27%
Poorly correlated
-0.32%
ALT - XBIO
26%
Poorly correlated
N/A
CGEN - XBIO
24%
Poorly correlated
-0.65%
More